SARDA PROTEINS LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.8 INR | 0.00% |
|
0.00% | +108.89% |
| 24/06 | Sarda Proteins Ltd Appoints Khilan Hareshbhai Savaliya as Additional Director (Non-Executive) | CI |
| 28/05 | Sarda Proteins Ltd Appoints Chirag Shantilal Thumar as Additional Executive Director | CI |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 8.146 | 10.8 | 18.85 | 18.05 | 64.38 | 99.69 |
| Enterprise Value (EV) 1 | 2.773 | 10.18 | 17.82 | 16.71 | 61.12 | 97.84 |
| P/E ratio | -2.46 x | -8.69 x | 57.5 x | -87.2 x | 21 x | -302 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.14 x | 0.15 x | 0.35 x | 0.16 x | 0.6 x | 1.72 x |
| EV / Revenue | 0.05 x | 0.14 x | 0.33 x | 0.15 x | 0.57 x | 1.69 x |
| EV / EBITDA | -0.76 x | -5.72 x | 18.6 x | -80.3 x | 22.6 x | -66.8 x |
| EV / FCF | 0.46 x | -1.7 x | 53.1 x | -35.3 x | -966 x | -40.1 x |
| FCF Yield | 215% | -58.9% | 1.88% | -2.83% | -0.1% | -2.49% |
| Price to Book | 0.37 x | 0.52 x | 0.9 x | 0.87 x | 2.7 x | 4.24 x |
| Nbr of stocks (in thousands) | 1,726 | 1,726 | 1,726 | 1,726 | 1,726 | 1,726 |
| Reference price 2 | 4.720 | 6.260 | 10.92 | 10.46 | 37.30 | 57.76 |
| Announcement Date | 08/08/18 | 04/09/19 | 04/09/20 | 24/08/21 | 25/08/22 | 02/09/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 56.32 | 71.45 | 54 | 113.6 | 107.6 | 57.95 |
| EBITDA 1 | -3.625 | -1.779 | 0.9579 | -0.2081 | 2.705 | -1.464 |
| EBIT 1 | -3.737 | -1.869 | 0.9247 | -0.2128 | 2.7 | -1.469 |
| Operating Margin | -6.64% | -2.62% | 1.71% | -0.19% | 2.51% | -2.53% |
| Earnings before Tax (EBT) 1 | -3.681 | -0.8739 | 1.705 | 0.6126 | 3.529 | 0.1293 |
| Net income 1 | -3.308 | -1.235 | 0.3292 | -0.2028 | 3.075 | -0.3303 |
| Net margin | -5.87% | -1.73% | 0.61% | -0.18% | 2.86% | -0.57% |
| EPS 2 | -1.917 | -0.7200 | 0.1900 | -0.1200 | 1.780 | -0.1914 |
| Free Cash Flow 1 | 5.969 | -5.996 | 0.3356 | -0.4734 | -0.0633 | -2.44 |
| FCF margin | 10.6% | -8.39% | 0.62% | -0.42% | -0.06% | -4.21% |
| FCF Conversion (EBITDA) | - | - | 35.03% | - | - | - |
| FCF Conversion (Net income) | - | - | 101.94% | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 08/08/18 | 04/09/19 | 04/09/20 | 24/08/21 | 25/08/22 | 02/09/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 5.37 | 0.62 | 1.02 | 1.34 | 3.26 | 1.84 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 5.97 | -6 | 0.34 | -0.47 | -0.06 | -2.44 |
| ROE (net income / shareholders' equity) | -14% | -5.8% | 1.58% | -0.97% | 13.8% | -1.39% |
| ROA (Net income/ Total Assets) | -8.89% | -5.17% | 2.66% | -0.62% | 7.36% | -3.78% |
| Assets 1 | 37.2 | 23.89 | 12.38 | 32.66 | 41.78 | 8.738 |
| Book Value Per Share 2 | 12.70 | 12.00 | 12.20 | 12.00 | 13.80 | 13.60 |
| Cash Flow per Share 2 | 3.110 | 0.4000 | 0.5900 | 0.7800 | 1.890 | 1.070 |
| Capex 1 | 0.2 | - | - | - | - | - |
| Capex / Sales | 0.36% | - | - | - | - | - |
| Announcement Date | 08/08/18 | 04/09/19 | 04/09/20 | 24/08/21 | 25/08/22 | 02/09/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +108.89% | 1.84M | |
| +35.59% | 7.5B | |
| -4.71% | 6.24B | |
| -5.09% | 4.91B | |
| +5.77% | 2.57B | |
| +34.49% | 2.11B | |
| -1.40% | 1.6B | |
| +14.45% | 1.01B | |
| +16.53% | 889M | |
| +2.75% | 679M |
- Stock Market
- Equities
- SRDAPRT Stock
- Financials Sarda Proteins Ltd
